Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY $761.50)
- $761.50 Fwd P/E: 64.26X Cap: $721.70B
- View LLY Profile
- View Questions on LLY

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $516.16)
- $516.16 Fwd P/E: 75.06X Cap: $185B
- View ISRG Profile
- View Questions on ISRG
AbbVie Inc. (ABBV $191.40)
- $191.40 Fwd P/E: 81.44X Cap: $338.08B
- View ABBV Profile
- View Questions on ABBV
Eli Lilly and Company (LLY $761.50)
- $761.50 Fwd P/E: 64.26X Cap: $721.70B
- View LLY Profile
- View Questions on LLY
Stryker Corporation (SYK $388.90)
- $388.90 Fwd P/E: 52.82X Cap: $148.62B
- View SYK Profile
- View Questions on SYK

Q: Previously had 3 U.S. ETFS for U.S. healthcare but haven't been happy about these.
Could you please suggest 3 or 4 U.S. healthcare companies that might work out for a 5 yr+ return. Please put in order of ratings and advise why you like them.
THank you
Margaret

Read Answer Asked by Margaret on July 15, 2025

Intuitive Surgical Inc. (ISRG $516.16)
- $516.16 Fwd P/E: 75.06X Cap: $185B
- View ISRG Profile
- View Questions on ISRG
Eli Lilly and Company (LLY $761.50)
- $761.50 Fwd P/E: 64.26X Cap: $721.70B
- View LLY Profile
- View Questions on LLY
UnitedHealth Group Incorporated (DE) (UNH $288.07)
- $288.07 Fwd P/E: 12.24X Cap: $261.31B
- View UNH Profile
- View Questions on UNH

Q: Hello, I've been holding UHN in my RRSP for a while, but the stock has taken a significant hit with a 33% loss. Given its current stagnation, I'm thinking of selling it and reallocating the funds. I have a few options in mind: I could buy a call option with a strike price of $79 expiring on Dec 27, which might give me a chance to recover some losses if the stock rebounds. Alternatively, I could sell UHN and use the proceeds to increase my stake in other healthcare stocks, such as LLY or ISRG, which I believe have more potential. Or, I could cut my losses entirely and exit the healthcare insurance sector. Which direction makes the most sense? Thanks

Read Answer Asked by Esther on July 10, 2025

Gilead Sciences Inc. (GILD $108.80)
- $108.80 Fwd P/E: 23.08X Cap: $135.33B
- View GILD Profile
- View Questions on GILD
Intuitive Surgical Inc. (ISRG $516.16)
- $516.16 Fwd P/E: 75.06X Cap: $185B
- View ISRG Profile
- View Questions on ISRG
AbbVie Inc. (ABBV $191.40)
- $191.40 Fwd P/E: 81.44X Cap: $338.08B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $162.98)
- $162.98 Fwd P/E: 18.33X Cap: $392.14B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $761.50)
- $761.50 Fwd P/E: 64.26X Cap: $721.70B
- View LLY Profile
- View Questions on LLY
Medtronic plc. (MDT $89.53)
- $89.53 Fwd P/E: 24.87X Cap: $114.71B
- View MDT Profile
- View Questions on MDT
Stryker Corporation (SYK $388.90)
- $388.90 Fwd P/E: 52.82X Cap: $148.62B
- View SYK Profile
- View Questions on SYK
Thermo Fisher Scientific Inc (TMO $424.98)
- $424.98 Fwd P/E: 24.42X Cap: $160.42B
- View TMO Profile
- View Questions on TMO
Health Care Select Sector SPDR (XLV $132.72)
- $132.72 Fwd P/E: 65.56X Cap: $33.74B
- View XLV Profile
- View Questions on XLV
iShares U.S. Medical Devices ETF (IHI $59.97)
- $59.97 Fwd P/E: 105.73X Cap: $4.37B
- View IHI Profile
- View Questions on IHI
Sabra Health Care REIT Inc. (SBRA $18.08)
- $18.08 Fwd P/E: 30.74X Cap: $4.39B
- View SBRA Profile
- View Questions on SBRA
Healthcare Realty Trust Incorporated (HR $16.20)
- $16.20 Cap: $5.65B
- View HR Profile
- View Questions on HR
iShares U.S. Pharmaceuticals ETF (IHE $67.36)
- $67.36 Fwd P/E: 57.72X Cap: $567M
- View IHE Profile
- View Questions on IHE
Catalyst Pharmaceuticals Inc. (CPRX $21.45)
- $21.45 Fwd P/E: 13.49X Cap: $2.61B
- View CPRX Profile
- View Questions on CPRX

Q: There was an article in the Globe and Mail today by David Rosenberg about the aging population and he suggested health care related investments such as health care REITS, pharma, devices, and services. What do you think of this idea and can you give me a few recommendations in canada and the US for each of the 4 categories (health reits, pharma, devices, sefrvices)? A mix of ETFS and individual stocks would be great.

Read Answer Asked by Carla on July 08, 2025